These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 24366041)

  • 1. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
    Xu C; Liu G; Liu X; Wang F
    Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy.
    Gurel Z; Sieg KM; Shallow KD; Sorenson CM; Sheibani N
    Mol Vis; 2013; 19():1047-59. PubMed ID: 23734074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased O-GlcNAcylation of NF-κB Enhances Retinal Ganglion Cell Death in Streptozotocin-induced Diabetic Retinopathy.
    Kim SJ; Yoo WS; Choi M; Chung I; Yoo JM; Choi WS
    Curr Eye Res; 2016; 41(2):249-57. PubMed ID: 25835259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of O-GlcNAcylation Modification in Diabetic Retinopathy and Crosstalk with Phosphorylation of STAT3 in Retina Vascular Endothelium Cells.
    Xu C; Liu GD; Feng L; Zhang CH; Wang F
    Cell Physiol Biochem; 2018; 49(4):1389-1402. PubMed ID: 30205382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells.
    Donovan K; Alekseev O; Qi X; Cho W; Azizkhan-Clifford J
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):7862-73. PubMed ID: 25352121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy.
    Dong W; Imdad L; Xu S; Wang Y; Liu C; Song S; Li Z; Kong Y; Kong L; Ren X
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The augmentation of O-GlcNAcylation reduces glyoxal-induced cell injury by attenuating oxidative stress in human retinal microvascular endothelial cells.
    Liu GD; Xu C; Feng L; Wang F
    Int J Mol Med; 2015 Oct; 36(4):1019-27. PubMed ID: 26311324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
    Goldberg H; Whiteside C; Fantus IG
    Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAc cycling enzymes control vascular development of the placenta by modulating the levels of HIF-1α.
    Yang YR; Jang HJ; Lee YH; Kim IS; Lee H; Ryu SH; Suh PG
    Placenta; 2015 Oct; 36(10):1063-8. PubMed ID: 26286378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-Linked β-
    Gurel Z; Sheibani N
    Clin Sci (Lond); 2018 Jan; 132(2):185-198. PubMed ID: 29352075
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Dierschke SK; Miller WP; Favate JS; Shah P; Imamura Kawasawa Y; Salzberg AC; Kimball SR; Jefferson LS; Dennis MD
    J Biol Chem; 2019 Apr; 294(14):5508-5520. PubMed ID: 30733333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
    Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of O-GlcNAc modification targets in mouse retinal pericytes: implication of p53 in pathogenesis of diabetic retinopathy.
    Gurel Z; Zaro BW; Pratt MR; Sheibani N
    PLoS One; 2014; 9(5):e95561. PubMed ID: 24788674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.
    Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H
    Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucosamine-induced Sp1 O-GlcNAcylation ameliorates hypoxia-induced SGLT dysfunction in primary cultured renal proximal tubule cells.
    Suh HN; Lee YJ; Kim MO; Ryu JM; Han HJ
    J Cell Physiol; 2014 Oct; 229(10):1557-68. PubMed ID: 24591095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
    Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-(1-7) Attenuates Protein O-GlcNAcylation in the Retina by EPAC/Rap1-Dependent Inhibition of O-GlcNAc Transferase.
    Dierschke SK; Toro AL; Barber AJ; Arnold AC; Dennis MD
    Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):24. PubMed ID: 32068794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aralia elata (Miq) Seem Extract Decreases O-GlcNAc Transferase Expression and Retinal Cell Death in Diabetic Mice.
    Kim YS; Kim M; Choi MY; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Park KH; Kim SJ; Yoo JM; Choi WS
    J Med Food; 2017 Oct; 20(10):989-1001. PubMed ID: 29040017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.